StockData
Skinvisible, Inc. logo

Skinvisible, Inc. (SKVI) stock

SKVIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.16+0.00 (+0.06%)

Close on Oct 19, 2026Market cap $843.54KP/E –Yield –

Skinvisible profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Skinvisible's profit margin for the twelve months ending Jun 30, 2026 was -5156.6%. For fiscal 2025 it was -5320.2%, against -2828.3% the year before. The highest annual figure on record is 228.3% in fiscal 2018.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-5320.2%−2491.9
FY2024Dec 31, 2024-2828.3%+9083.9
FY2023Dec 31, 2023-11912.2%−11473.6
FY2022Dec 31, 2022-438.6%−276.9
FY2021Dec 31, 2021-161.7%+786.7
FY2020Dec 31, 2020-948.4%+3097.9
FY2019Dec 31, 2019-4046.3%−4274.7
FY2018Dec 31, 2018228.3%+518.8
FY2017Dec 31, 2017-290.4%+1593.0
FY2016Dec 31, 2016-1883.4%−743.8
FY2015Dec 31, 2015-1139.6%+2367.7
FY2014Dec 31, 2014-3507.3%−1493.1
FY2013Dec 31, 2013-2014.3%−1476.9
FY2012Dec 31, 2012-537.3%+217.7
FY2011Dec 31, 2011-755.0%−286.8
FY2010Dec 31, 2010-468.2%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-5110.7%+377.9
Q1 FY2026Mar 31, 2026-5343.7%+276.4
Q4 FY2025Dec 31, 2025-5167.1%−11462.6
Q3 FY2025Sep 30, 2025-5004.9%+727.2
Q2 FY2025Jun 30, 2025-5488.5%+580.4
Q1 FY2025Mar 31, 2025-5620.1%+187.3
Q4 FY2024Dec 31, 20246295.4%+12371.2
Q3 FY2024Sep 30, 2024-5732.1%+18.3
Q2 FY2024Jun 30, 2024-6069.0%−547.5
Q1 FY2024Mar 31, 2024-5807.4%+24493.7
Q4 FY2023Dec 31, 2023-6075.8%+1935.7
Q3 FY2023Sep 30, 2023-5750.4%−1262.7
Q2 FY2023Jun 30, 2023-5521.5%−5456.1
Q1 FY2023Mar 31, 2023-30301.1%−30118.6
Q4 FY2022Dec 31, 2022-8011.5%−7918.0
Q3 FY2022Sep 30, 2022-4487.6%−873.8
Q4 FY2021Dec 31, 2021-65.4%+159.7
Q3 FY2021Sep 30, 2021-182.5%+9613.3
Q2 FY2021Jun 30, 2021-93.5%+3382.0
Q1 FY2021Mar 31, 2021-3613.8%−934.5
Q4 FY2020Dec 31, 2020-225.1%+3736.0
Q3 FY2020Sep 30, 2020-9795.8%−6708.2
Q2 FY2020Jun 30, 2020-3475.5%+1145.4
Q1 FY2020Mar 31, 2020-2679.3%+1421.3
Q4 FY2019Dec 31, 2019-3961.1%−2568.6
Q3 FY2019Sep 30, 2019-3087.6%−6493.8
Q2 FY2019Jun 30, 2019-4620.8%−2840.8
Q1 FY2019Mar 31, 2019-4100.6%−4718.1
Q4 FY2018Dec 31, 2018-1392.5%−1368.5
Q3 FY2018Sep 30, 20183406.2%+4305.3
Q2 FY2018Jun 30, 2018-1780.0%−169.6
Q1 FY2018Mar 31, 2018617.5%+4445.7
Q4 FY2017Dec 31, 2017-24.0%+1823.6
Q3 FY2017Sep 30, 2017-899.1%+1980.6
Q2 FY2017Jun 30, 2017-1610.4%−393.2
Q1 FY2017Mar 31, 2017-3828.2%–
Q4 FY2016Dec 31, 2016-1847.6%–
Q3 FY2016Sep 30, 2016-2879.7%–
Q2 FY2016Jun 30, 2016-1217.2%–

More Skinvisible figures

See a number that looks wrong?